PC
OXFD

Polar Capital’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

Polar Capital’s Portfolio OXFD Stock Details OXFD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$30.1M Hold
2,568,385
– – 0.22% 102
2020
Q2 		$33.4M Hold
2,568,385
– – 0.29% 95
2020
Q1 		$23.8M Hold
2,568,385
– – 0.26% 114
2019
Q4 		$42.6M Hold
2,568,385
– – 0.37% 88
2019
Q3 		$42.7M Hold
2,568,385
– – 0.38% 79
2019
Q2 		$35.3M Buy
2,568,385
+10,412
+0.4% +$159K 0.31% 104
2019
Q1 		$44.1M Hold
2,557,973
– – 0.41% 84
2018
Q4 		$32.7M Buy
2,557,973
+58,351
+2% +$885K 0.35% 96
2018
Q3 		$40.6M Sell
2,499,622
-400
-0% -$5.72K 0.35% 91
2018
Q2 		$32.2M Hold
2,500,022
– – 0.19% 110
2018
Q1 		$31.1M Buy
2,500,022
+35,000
+1% +$426K 0.31% 114
2017
Q4 		$34.4M Buy
2,465,022
+100,000
+4% +$1.46M 0.36% 88
2017
Q3 		$39.7M Buy
2,365,022
+262,545
+12% +$4.27M 0.45% 72
2017
Q2 		$35.4M Buy
2,102,477
+47,108
+2% +$704K 0.48% 72
2017
Q1 		$31.8M Buy
2,055,369
+322,766
+19% +$4.61M 0.48% 69
2016
Q4 		$25.9M Buy
1,732,603
+239,420
+16% +$3.36M 0.41% 77
2016
Q3 		$18.8M Buy
1,493,183
+152,312
+11% +$1.53M 0.32% 102
2016
Q2 		$12.1M Buy
1,340,871
+978
+0.1% +$9.58K 0.23% 124
2016
Q1 		$13.3M Buy
1,339,893
+31,502
+2% +$323K 0.25% 112
2015
Q4 		$15M Buy
1,308,391
+259,773
+25% +$3.21M 0.27% 108
2015
Q3 		$14.2M Buy
1,048,618
+175,629
+20% +$2.38M 0.29% 112
2015
Q2 		$12.1M Buy
872,989
+369,978
+74% +$5M 0.23% 131
2015
Q1 		$7.08M Buy
503,011
+476,927
+1,828% +$6.49M 0.13% 152
2014
Q4 		$355K Buy
26,084
+12,403
+91% +$170K 0.01% 266
2014
Q3 		$209K Buy
13,681
+3,292
+32% +$50.4K ﹤0.01% 267
2014
Q2 		$175K Buy
+10,389
New +$187K ﹤0.01% 264
2014
Q1 		– Sell
-301,078
Closed -$5.83M – 283
2013
Q4 		$5.83M Buy
+301,078
New +$5.32M 0.14% 183

Other funds holding OXFD

FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
ECM
Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return
GPGA
Grandeur Peak Global Advisors Salt Lake City, Utah $432M AUM 42.58% 1-Year Est. Return
SM
Senvest Management New York $3.41B AUM 66.27% 1-Year Est. Return
PCM
Penn Capital Management Philadelphia, Pennsylvania $1.58B AUM 81.2% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Polar Capital's OXFD Position: Q3 2020 in Review

Polar Capital held its Oxford Immunotec Global PLC Ordinary Shares (OXFD) position steady in Q3 2020 at 2,568,385 shares worth $30.1M. The position accounts for 0.22% of the portfolio, ranked #102.

Polar Capital first reported a position in OXFD in Q4 2013 and has held it in 27 quarters since. The position peaked at $44.1M in Q1 2019. 71 funds tracked by Wall St. Rank hold OXFD as of Q3 2020.

  • Polar Capital held 2,568,385 shares of Oxford Immunotec Global PLC Ordinary Shares worth $30.1M as of Q3 2020.
  • Polar Capital left its Oxford Immunotec Global PLC Ordinary Shares share count unchanged in Q3 2020.
  • Oxford Immunotec Global PLC Ordinary Shares made up 0.22% of Polar Capital's portfolio in Q3 2020, its #102 holding.
  • Polar Capital first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q4 2013 and has held it in 27 quarters since.
  • Polar Capital's Oxford Immunotec Global PLC Ordinary Shares position peaked at $44.1M in Q1 2019.
  • 71 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q3 2020.

Based on Polar Capital's 13F filing for Q3 2020, filed 16 Nov 2020.